Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: Is it necessary for all?
Phillip K. Pellitteri(Geisinger Medical Center), WI Wei(New York University), K. Thomas Robbins(Southern Illinois University School of Medicine), Alfio Ferlito(University of Padua), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Ashok R. Shaha(Memorial Sloan Kettering Cancer Center), Randal S. Weber(The University of Texas MD Anderson Cancer Center), Luiz Paulo Kowalski(Translational Research in Oncology), Carlos Suárez(Hospital Universitario Central de Asturias), Alessandra Rinaldo(University of Udine), C. René Leemans(Amsterdam University Medical Centers), Christine G. Gourin(Johns Hopkins University), Jean Louis Lefèbvre(Centre Oscar Lambret), John Lowry(Royal Bolton Hospital), Jesús E. Medina(Centro Medico Nacional Siglo XXI), Eric M. Genden(Icahn School of Medicine at Mount Sinai)
Cited by 83
Related Papers
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
|Head & Neck|2005|1.8k
The molecular landscape of head and neck cancer
|Nature reviews. Cancer|2018|1.4k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
|Thyroid|2021|699
Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With Radiotherapy
|Journal of Clinical Oncology|2008|687